Skip to main content
. 2022 Oct 14;16(1):230–243. doi: 10.1080/19336950.2022.2122309

Table 3.

Inhibition of contractility in ex vivo HMD assay of inhibitors SSCI-1, 3–6.

Compound Ex vivo HMD IC50 (μM)
SSCI-3 2.7
SSCI-4 8.9
SSCI-5 11
SSCI-1 >30
SSCI-6 130% at 10